JAKARTA (Yosefardi) – Pharmaceutical firm PT Taisho Pharmaceutical Indonesia Tbk booked net profit of Rp164.8 billion in 2014, grew by 10.7% from Rp149.5 billion in 2013.
Net sales increased 16.6% to Rp497.5 billion from previous Rp426.43 billion. Cost of goods sold also rose 22.4% to Rp202 billion from earlier Rp165 billion. Sales to PT Dos Ni Roha reached Rp345.92 billion, grew by 14.5% from Rp301.75 billion in 2013.
Its assets reached Rp459.35 billion while liability amounted Rp90.47 billion. The company has cash and cash equivalent of Rp192.78 billion.